CLOSTRIDIUM DIFFICILE
Clinical trials for CLOSTRIDIUM DIFFICILE explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIUM DIFFICILE trials appear
Sign up with your email to follow new studies for CLOSTRIDIUM DIFFICILE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cocktail of good bacteria break the cycle of c. diff?
Disease control Recruiting nowThis large Phase 3 trial tests whether VE303, a capsule containing 8 harmless bacteria, can prevent repeat Clostridioides difficile (C. diff) infections. About 852 people who have had at least one prior C. diff infection will take VE303 or a placebo for 14 days. The main goal is …
Matched conditions: CLOSTRIDIUM DIFFICILE
Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Multiple fecal transplants may beat single dose for c. diff in colitis patients
Disease control Recruiting nowThis study tests whether giving several fecal transplants (instead of just one) works better to clear repeat C. diff infections in people with ulcerative colitis. About 64 adults with active colitis and repeat C. diff will receive either one or multiple infusions of healthy donor…
Matched conditions: CLOSTRIDIUM DIFFICILE
Phase: PHASE1, PHASE2 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC